PRESTIGE CONSUMER HEALTHCARE (PBH) Stock News
NYSE:PBH - New York Stock Exchange, Inc. - US74112D1019 - Common Stock - Currency: USD
PBH Latest News, Press Relases and Analysis
PBH vs. ESLOY: Which Stock Should Value Investors Buy Now?
PBH vs. ESLOY: Which Stock Is the Better Value Option?
Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase
PBH experiences steady international growth in the fourth quarter, banking on strong sales of the Hydralyte brand.
Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of 1.54% and 2.62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MDT
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
PBH or ABT: Which Is the Better Value Stock Right Now?
PBH vs. ABT: Which Stock Is the Better Value Option?
Mentions: ABT
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal...
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal...
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Insights Into Prestige Consumer Healthcare (PBH) Q4: Wall Street Projections for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Prestige Consumer Healthcare (PBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Prestige Consumer Healthcare (PBH) Reports Next Week: Wall Street Expects Earnings Growth
Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: PRGO
EMEA Growth & Product Launches to Support Boston Scientific Stock
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025...
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
Prestige Consumer Gains 17.1% in a Year: What's Driving the Stock?
PBH's shares rise on the back of its portfolio of consumer brands and focus on core strategies to achieve long-term success.
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
Revenue of $290.3 million in Q3, up 2.7% versus prior yearDiluted EPS of $1.22 in Q3 increased approximately 15% versus prior yearReduced leverage to 2.5x...
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
TARRYTOWN, N.Y., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 third...
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
Revenue of $283.8 Million in Q2, Ahead of OutlookDiluted EPS of $1.09 in Q2, Up 2% Versus Prior YearNet Cash Provided by Operating Activities of...
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
TARRYTOWN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2024.
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first...
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual...